bluebird bio, Inc.
BLUE
$4.95
$0.061.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 52.78% | 25.29% | -16.60% | 13.63% | 7.35% |
| Total Depreciation and Amortization | -9.38% | -7.15% | 6.83% | 74.50% | 19.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.00% | -20.41% | 73.36% | -55.60% | -45.28% |
| Change in Net Operating Assets | -31.23% | -109.58% | 41.61% | -978.95% | 64.92% |
| Cash from Operations | 27.22% | -4.04% | 11.28% | -37.94% | -8.16% |
| Capital Expenditure | -73.21% | -374.58% | 96.68% | -46.21% | 40.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 295.44% | -55.60% | 50.00% | -77.60% | -92.20% |
| Cash from Investing | 428.97% | -71.25% | 347.48% | -117.30% | -93.90% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | 21.77% | 20.82% | -19.02% | -57.88% | -19.27% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 246.45% | -27.23% | 31.12% | 542.90% | -- |
| Cash from Financing | 673.14% | -0.73% | -109.38% | -39.34% | 1,000.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.96% | -5.48% | -561.54% | -119.00% | 28,734.87% |
